183 related articles for article (PubMed ID: 22135700)
21. Bisphosphonate-related osteonecrosis of the jaw in metastatic breast cancer patients: a review of 25 cases.
Kim HJ; Park TJ; Ahn KM
Maxillofac Plast Reconstr Surg; 2016 Dec; 38(1):6. PubMed ID: 26870717
[TBL] [Abstract][Full Text] [Related]
22. Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction.
Spanou A; Nelson K; Ermer MA; Steybe D; Poxleitner P; Voss PJ
Quintessence Int; 2020; 51(3):220-228. PubMed ID: 32020132
[TBL] [Abstract][Full Text] [Related]
23. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
Wutzl A; Eisenmenger G; Hoffmann M; Czerny C; Moser D; Pietschmann P; Ewers R; Baumann A
Wien Klin Wochenschr; 2006 Aug; 118(15-16):473-8. PubMed ID: 16957978
[TBL] [Abstract][Full Text] [Related]
24. [Avascular necrosis of the jaw bone after bisphosphonate therapy].
Shlomi B; Levy Y; Kleinman S; Better H; Kahn A; Shtabsky A; Chaushu G
Harefuah; 2005 Aug; 144(8):536-9, 600, 599. PubMed ID: 16146148
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate.
Okawa H; Kondo T; Hokugo A; Cherian P; Campagna JJ; Lentini NA; Sung EC; Chiang S; Lin YL; Ebetino FH; John V; Sun S; McKenna CE; Nishimura I
Elife; 2022 Aug; 11():. PubMed ID: 36017995
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Migliorati CA; Schubert MM; Peterson DE; Seneda LM
Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
[TBL] [Abstract][Full Text] [Related]
27. Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy.
Vieillard MH; Maes JM; Penel G; Facon T; Magro L; Bonneterre J; Cortet B
Joint Bone Spine; 2008 Jan; 75(1):34-40. PubMed ID: 17981488
[TBL] [Abstract][Full Text] [Related]
28. Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Rollason V; Laverrière A; MacDonald LC; Walsh T; Tramèr MR; Vogt-Ferrier NB
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008455. PubMed ID: 26919630
[TBL] [Abstract][Full Text] [Related]
29. Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw.
Janovska Z; Mottl R; Slezak R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):313-7. PubMed ID: 24108250
[TBL] [Abstract][Full Text] [Related]
30. Tooth extraction in osteoporotic patients taking oral bisphosphonates.
Mozzati M; Arata V; Gallesio G
Osteoporos Int; 2013 May; 24(5):1707-12. PubMed ID: 23288026
[TBL] [Abstract][Full Text] [Related]
31. Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice.
Kuroshima S; Nakajima K; Sasaki M; I T; Sumita Y; Asahara T; Asahina I; Sawase T
Stem Cell Res Ther; 2019 Jul; 10(1):209. PubMed ID: 31311585
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case.
Shirota T; Nakamura A; Matsui Y; Hatori M; Nakamura M; Shintani S
Clin Oral Implants Res; 2009 Dec; 20(12):1402-8. PubMed ID: 19793318
[TBL] [Abstract][Full Text] [Related]
33. Extensive osteonecrosis of the maxilla caused by bisphosphonates: Report of a rare case.
Santos M; Silveira K; Souza N; Costa D; Inaoka S
J Clin Exp Dent; 2019 Feb; 11(2):e203-e207. PubMed ID: 30805126
[TBL] [Abstract][Full Text] [Related]
34. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.
Fugazzotto PA; Lightfoot WS; Jaffin R; Kumar A
J Periodontol; 2007 Sep; 78(9):1664-9. PubMed ID: 17760533
[TBL] [Abstract][Full Text] [Related]
35. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
36. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for medication-related osteonecrosis of the jaw and salivary IL-6 IN cancer patients.
Kemp APT; Ferreira VHC; Mobile RZ; Brandão TB; Sassi LM; Zarpellon A; Braz-Silva PH; Schussel JL
Braz J Otorhinolaryngol; 2022; 88(5):683-690. PubMed ID: 33189595
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate-related osteonecrosis of the jaws--a case report.
Kamoh AK; Ogle O
Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
[TBL] [Abstract][Full Text] [Related]
39. The effects of bisphosphonate on the remodeling of different irregular bones in mice.
Su J; Feng M; Han W; Zhao H
J Oral Pathol Med; 2015 Sep; 44(8):638-48. PubMed ID: 25370709
[TBL] [Abstract][Full Text] [Related]
40. [Osteonecrosis of the jaws by long term therapy with bisphosphonates].
Piesold JU; Al-Nawas B; Grötz KA
Mund Kiefer Gesichtschir; 2006 Sep; 10(5):287-300. PubMed ID: 16960697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
